Genetically modified bacillus subtilis strain and use as a live delivery and production system
US-2024390433-A1 · Nov 28, 2024 · US
Method for stimulating the intestinal flora
US2016100618A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016100618-A1 |
| Application number | US-201514973166-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 17, 2015 |
| Priority date | Oct 21, 2005 |
| Publication date | Apr 14, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.
First claim
Opening claim text (preview).
1 . A method for feeding an infant delivered via caesarean section, wherein said method comprises: (i) identifying an infant delivered via caesarean section; and (ii) enterally administering to the infant a composition comprising: (a) a Bifidobacterium consisting of Bifidobacterium breve; and (b) at least one indigestible galacto-oligosaccharide. 2 . The method of claim 1 , wherein the composition further comprises an indigestible oligosaccharide selected from the group consisting of indigestible dextrins, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligo-saccharides, isomalto-oligosaccharide and fructopolysaccharides. 3 . The method of claim 1 , wherein the composition comprises between 5 and 25 energy % protein, between 25 and 60 energy % fat and between 30 and 70 energy % carbohydrate. 4 . The method of claim 1 , wherein the composition is administered to an infant receiving human breast milk. 5 . The method of claim 1 , wherein the composition is administered to the infant within one week after birth. 6 . The method of claim 1 , wherein the composition is admixed with a nutritionally or pharmaceutically acceptable liquid prior to administering the composition to the infant. 7 . The method of claim 1 , wherein the composition stimulates the intestinal flora of the infant. 8 . The method of claim 7 , wherein the composition is administered to the infant within 100 hours after birth.
Assignees
Inventors
Classifications
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Immunomodulators · CPC title
Antibacterial agents · CPC title
Ophthalmic agents · CPC title
Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016100618A1 cover?
- The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composi…
- Who is the assignee on this patent?
- Nutricia Nv
- What technology area does this patent fall under?
- Primary CPC classification A23L33/135. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Apr 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).